journal article·2023-07-10Open access

Thiol-Michael Addition Microparticles: Their Synthesis, Characterization, and Uptake by Macrophages

Emerson L. Grey, Jazalle McClendon, Joshita Suresh, Scott Alper, William J. Janssen, Stephanie J. Bryant

Abstract

Polymeric microparticles are promising biomaterial platforms for targeting macrophages in the treatment of disease. This study investigates microparticles formed by a thiol-Michael addition step-growth polymerization reaction with tunable physiochemical properties and their uptake by macrophages. The hexafunctional thiol monomer dipentaerythritol hexa-3-mercaptopropionate (DPHMP) and tetrafunctional acrylate monomer di(trimethylolpropane) tetraacrylate (DTPTA) were reacted in a stepwise dispersion polymerization, achieving tunable monodisperse particles over a size range (1–10 μm) relevant for targeting macrophages. An off-stoichiometry thiol-acrylate reaction afforded facile secondary chemical functionalization to create particles with different chemical moieties. Uptake of the microparticles by RAW 264.7 macrophages was highly dependent on treatment time, particle size, and particle chemistry with amide, carboxyl, and thiol terminal chemistries. The amide-terminated particles were non-inflammatory, while the carboxyl- and thiol-terminated particles induced pro-inflammatory cytokine production in conjunction with particle phagocytosis. Finally, a lung-specific application was explored through time-dependent uptake of amide-terminated particles by human alveolar macrophages in vitro and mouse lungs in vivo without inducing inflammation. The findings demonstrate a promising microparticulate delivery vehicle that is cyto-compatible, is non-inflammatory, and exhibits high rates of uptake by macrophages.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biological Engineering, University of Colorado, 3415 Colorado Ave., Boulder, Colorado 80309-0596, United States

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, 1400 Jackson St., Denver, Colorado 80206, United States

Department of Immunology and Genomic Medicine, Center for Genes, Environment and Health, National Jewish Health, 1400 Jackson St., Denver, Colorado 80206, United States

Department of Medicine, University of Colorado Anschutz Medical Campus, 12631 East 17th Avenue, Aurora, Colorado 80045, United States

Materials Science & Engineering Program, University of Colorado, 4001 Discovery Dr., Boulder, Colorado 80309-0613, United States

BioFrontiers Institute, University of Colorado, 3415 Colorado Ave., Boulder, Colorado 80309-0596, United States

Funding

National Heart, Lung, and Blood Institute · National Institute of Biomedical Imaging and Bioengineering · National Science Foundation

References (69)

Show source-provided references
1. 10.1016/j.addr.2014.02.00210.1016/j.addr.2014.02.002 ↗
2. 10.1016/j.jddst.2022.10365910.1016/j.jddst.2022.103659 ↗
3. 10.3389/fimmu.2019.0070710.3389/fimmu.2019.00707 ↗
4. 10.1016/j.ejpb.2014.12.00110.1016/j.ejpb.2014.12.001 ↗
5. 10.1016/j.cbi.2019.02.02110.1016/j.cbi.2019.02.021 ↗
6. 10.1088/2053-1591/ac3f5e10.1088/2053-1591/ac3f5e ↗
7. 10.1016/j.bpj.2014.07.07010.1016/j.bpj.2014.07.070 ↗
8. 10.1016/j.ejps.2010.09.00610.1016/j.ejps.2010.09.006 ↗
9. 10.1016/j.jconrel.2009.11.02010.1016/j.jconrel.2009.11.020 ↗
10. 10.1002/jbm.a.3661710.1002/jbm.a.36617 ↗
11. 10.1016/j.actbio.2019.11.02110.1016/j.actbio.2019.11.021 ↗
12. 10.1007/s11095-008-9562-y10.1007/s11095-008-9562-y ↗
13. 10.1007/s11095-010-0094-x10.1007/s11095-010-0094-x ↗
14. 10.1016/j.intimp.2011.05.01410.1016/j.intimp.2011.05.014 ↗
15. 10.3390/nano812102810.3390/nano8121028 ↗
16. 10.3109/17435390.2015.102288710.3109/17435390.2015.1022887 ↗
17. 10.1016/S0927-7765(02)00042-510.1016/S0927-7765(02)00042-5 ↗
18. 10.1517/17425247.2015.103950910.1517/17425247.2015.1039509 ↗
19. 10.3390/pharmaceutics1402035910.3390/pharmaceutics14020359 ↗
20. 10.1016/j.jconrel.2007.01.01310.1016/j.jconrel.2007.01.013 ↗
21. 10.1016/j.partic.2022.03.00310.1016/j.partic.2022.03.003 ↗
22. 10.1016/j.msec.2021.11261210.1016/j.msec.2021.112612 ↗
23. 10.1016/j.colsurfb.2016.05.08510.1016/j.colsurfb.2016.05.085 ↗
24. 10.1016/j.jconrel.2004.11.02510.1016/j.jconrel.2004.11.025 ↗
25. 10.1016/j.jconrel.2010.07.11610.1016/j.jconrel.2010.07.116 ↗
26. 10.1039/D2SM01152B10.1039/D2SM01152B ↗
27. 10.1016/j.ijpharm.2014.02.03710.1016/j.ijpharm.2014.02.037 ↗
28. 10.1242/jcs.115.4.84910.1242/jcs.115.4.849 ↗
29. 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-510.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5 ↗
30. 10.1002/anie.20090392410.1002/anie.200903924 ↗
31. 10.1016/j.progpolymsci.2011.11.00810.1016/j.progpolymsci.2011.11.008 ↗
32. 10.1016/j.polymer.2016.10.01610.1016/j.polymer.2016.10.016 ↗
33. 10.1039/C6PY01824F10.1039/C6PY01824F ↗
34. 10.1002/adma.20090037310.1002/adma.200900373 ↗
35. 10.1002/marc.20180016910.1002/marc.201800169 ↗
36. 10.1039/C6PY02094A10.1039/C6PY02094A ↗
37. 10.1021/acs.langmuir.0c0279810.1021/acs.langmuir.0c02798 ↗
38. 10.1039/C4MH00082J10.1039/C4MH00082J ↗
39. 10.1021/acs.macromol.5b0214610.1021/acs.macromol.5b02146 ↗
40. 10.1021/acs.biomac.0c0156310.1021/acs.biomac.0c01563 ↗
41. 10.1164/rccm.201911-2105OC10.1164/rccm.201911-2105OC ↗
42. 10.1002/app.1993.07050021210.1002/app.1993.070500212 ↗
43. 10.1002/(SICI)1099-0518(19960130)34:2<175::AID-POLA3>3.0.CO;2-T10.1002/(SICI)1099-0518(19960130)34:2<175::AID-POLA3>3.0.CO;2-T ↗
44. 10.1021/bc100501510.1021/bc1005015 ↗
45. 10.1021/la049247q10.1021/la049247q ↗
46. 10.2310/7290.2011.0000810.2310/7290.2011.00008 ↗
47. 10.1016/j.actbio.2006.12.00110.1016/j.actbio.2006.12.001 ↗
48. 10.1002/jbm.a.3048710.1002/jbm.a.30487 ↗
49. 10.1016/j.ajps.2020.07.00510.1016/j.ajps.2020.07.005 ↗
50. 10.1126/science.276.5320.186810.1126/science.276.5320.1868 ↗
51. 10.3389/fimmu.2020.60794510.3389/fimmu.2020.607945 ↗
52. 10.1557/mrc.2019.15410.1557/mrc.2019.154 ↗
53. 10.1146/annurev.immunol.20.103001.11474410.1146/annurev.immunol.20.103001.114744 ↗
54. 10.1016/S0939-6411(98)00038-110.1016/S0939-6411(98)00038-1 ↗
55. 10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
56. 10.1016/j.actbio.2020.03.03310.1016/j.actbio.2020.03.033 ↗
57. 10.1016/0924-8579(96)00007-610.1016/0924-8579(96)00007-6 ↗
58. 10.1096/fj.08-12122810.1096/fj.08-121228 ↗
59. 10.1097/SHK.000000000000154110.1097/SHK.0000000000001541 ↗
60. 10.1016/j.it.2009.07.00910.1016/j.it.2009.07.009 ↗
61. 10.1016/j.actbio.2010.07.03310.1016/j.actbio.2010.07.033 ↗
62. 10.1021/bm501138210.1021/bm5011382 ↗
63. 10.1038/s41598-021-86202-510.1038/s41598-021-86202-5 ↗
64. 10.3389/fimmu.2018.0177710.3389/fimmu.2018.01777 ↗
65. 10.1111/imcb.1223510.1111/imcb.12235 ↗
66. 10.1136/thoraxjnl-2015-20702010.1136/thoraxjnl-2015-207020 ↗
67. 10.1172/JCI12461510.1172/JCI124615 ↗
68. 10.3390/cells1004089710.3390/cells10040897 ↗
69. 10.1152/ajplung.00058.201710.1152/ajplung.00058.2017 ↗